Caricamento...
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
BACKGROUND: Currently licensed human vaccines are subtype-specific and do not protect against pandemic H5N1 viruses. Previously, our group has reported on the construction of an influenza virus-like particle (VLP) as a new generation candidate vaccine. A mixture of influenza H5N1 VLPs representing c...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2583969/ https://ncbi.nlm.nih.gov/pubmed/18957098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-5-131 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|